Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Oslo Bors  >  PCI Biotech Holding ASA    PCIB   NO0010405640

PCI BIOTECH HOLDING ASA

(PCIB)
  Report
Delayed Quote. Delayed Oslo Bors - 07/10 10:25:27 am
70.3 NOK   -0.85%
05/27PCI BIOTECH : Minutes from Annual General Meeting 2020
GL
05/06PCI BIOTECH : Notice of Annual General Meeting 2020
GL
05/06PCI BIOTECH : Q1 2020 Interim Report
PU
SummaryQuotesChartsNewsCalendarCompanyFinancials 
Valuation
Fiscal Period: December 2014 2015 2016 2017 2018 2019
Capitalization1 10059,62241 0529772 858
Entreprise Value (EV)1 84,710,42101 0016282 598
P/E ratio -2,80x-1,75x-6,94x-23,9x-21,0x-32,2x
Yield ------
Capitalization / Revenue 13,8x5,69x21,3x103x102x304x
EV / Revenue 11,6x0,99x20,0x97,7x65,5x277x
EV / EBITDA -2,32x-0,32x-6,34x-23,1x-14,1x-29,4x
Price to Book 11,0x1,35x17,1x25,1x2,88x11,2x
Nbr of stocks (in thousands) 7 72614 90014 90024 98737 16537 266
Reference price (NOK) 13,04,0015,042,126,376,7
Last update 04/11/201604/25/201703/19/201804/09/201904/22/202004/22/2020
1 NOK in Million
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2014 2015 2016 2017 2018 2019
Net sales1 7,3010,510,510,39,599,39
EBITDA1 -36,5-32,6-33,0-43,4-44,5-88,5
Operating profit (EBIT)1 -36,5-32,6-33,0-43,4-44,5-88,8
Operating Margin -500%-312%-315%-424%-464%-946%
Pre-Tax Profit (EBT)1 -35,8-31,9-32,2-42,8-34,8-88,7
Net income1 -35,8-31,9-32,2-42,8-34,8-88,7
Net margin -491%-305%-307%-418%-363%-945%
EPS2 -4,64-2,29-2,16-1,76-1,25-2,38
Dividend per Share ------
Last update 04/11/201604/25/201703/19/201804/09/201904/22/202004/22/2020
1 NOK in Million
2 NOK
Balance Sheet Analysis
Fiscal Period: December 2014 2015 2016 2017 2018 2019
Net Debt1 ------
Net Cash position1 15,849,214,050,8349260
Leverage (Debt / EBITDA) 0,43x1,51x0,42x1,17x7,85x2,94x
Free Cash Flow1 -17,7-20,4-23,7-13,9-23,4-53,0
ROE (Net Profit / Equities) -137%-120%-112%-156%-18,2%-29,8%
Shareholders' equity1 26,326,728,727,5191297
ROA (Net Profit / Asset) -62,4%-53,1%-52,4%-67,2%-13,4%-17,4%
Assets1 57,560,161,463,8260511
Book Value Per Share2 1,182,970,881,679,156,84
Cash Flow per Share2 2,043,310,942,039,407,01
Capex -----5,41
Capex / Sales -----57,5%
Last update 04/11/201604/25/201703/19/201804/09/201904/22/202004/22/2020
1 NOK in Million
2 NOK
Finances - Leverage
Financial data source
© 2020 S&P Global Market Intelligence
Key data
Capitalization (NOK)
2 619 792 067
Capitalization (USD)
277 721 871
Net sales (NOK)
9 392 000
Net sales (USD)
995 336
Number of employees
9
Sales / Employee (NOK)
1 043 556
Sales / Employee (USD)
110 593
Free-Float
65,1%
Free-Float capitalization (NOK)
1 705 906 127
Free-Float capitalization (USD)
180 841 620
Avg. Exchange 20 sessions (NOK)
32 416 961
Avg. Exchange 20 sessions (USD)
3 435 452
Average Daily Capital Traded
1,2%
EPS & Dividend